Why RenovoRx Stock Is Trading Higher Today

RenovoRx RNXT shares are trading higher after the company was granted FDA clearance for 'Catheter, Intravascular Occluding, Temporary.'

RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.

At last check, RenovoRx was trading 102.4% higher at $15.61 per share. The stock has a 52-week high of $16.43 and a 52-week low $6.66.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Newswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!